Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, T.
Right arrow Articles by DiGiovanni, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, T.
Right arrow Articles by DiGiovanni, J.
[Cancer Research 63, 4819-4828, August 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Targeted Expression of c-Src in Epidermal Basal Cells Leads to Enhanced Skin Tumor Promotion, Malignant Progression, and Metastasis1

Takashi Matsumoto, Jianghong Jiang, Kaoru Kiguchi, Lynnsie Ruffino, Steve Carbajal, Linda Beltrán, David K. Bol, Michael P. Rosenberg and John DiGiovanni2

Department of Carcinogenesis, University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957 [T. M., J. J., K. K., L. R., S. C., L. B., J. D.]; Avalon Pharmaceuticals, Inc., Gaithersburg, Maryland 20878 [D. K. B.]; and Piedmont Research Center, Morrisville, North Carolina 27560 [M. P. R.]

In this study, we generated transgenic mice that overexpressed either a constitutively active human c-src mutant (src530) or a wild-type human c-src (srcwt) in epidermal basal cells driven by human keratin 14 (HK14) or bovine keratin 5 (BK5) promoters, respectively. HK14.src530 transgenic mice developed severe epidermal hyperplasia and hyperkeratosis, and did not survive beyond 3 weeks of age. Four transgenic founders were obtained after injection of a BK5.srcwt construct with variable phenotypes, and three lines (lines A-C) were established. BK5.srcwt founder D exhibited a severe skin phenotype similar to HK14.src530 transgenic mice and died 5 days after birth. Line C transgenic mice also exhibited significant epidermal hyperplasia and hyperkeratosis, and developed spontaneous squamous cell carcinomas (SCCs) of the skin beginning at ~3 months of age (70% incidence at 1 year). Mice from lines A and B did not show a marked phenotype; however, elevated human srcwt protein in the epidermis of line B mice was clearly evident. Additional analyses of line B transgenic mice showed an enhanced responsiveness to 12-O-tetradecanoylphorbol-13-acetate-induced epidermal hyperplasia and cell proliferation. Analysis of the susceptibility of line B mice to two-stage skin carcinogenesis revealed that papillomas and SCCs arose earlier and in greater numbers compared with nontransgenic littermates. In addition, malignant conversion occurred more rapidly, and the SCCs that developed in line B transgenic mice had a greater propensity to metastasize to peripheral lymph nodes and other organs. These observations support the hypothesis that c-src plays an important role in skin tumor promotion. In addition, the data show that elevated c-src activity enhances malignant progression and metastasis in this model system.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. K. Jung, K. W. Lee, S. Byun, N. J. Kang, S. H. Lim, Y.-S. Heo, A. M. Bode, G. T. Bowden, H. J. Lee, and Z. Dong
Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn
Cancer Res., July 15, 2008; 68(14): 6021 - 6029.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer
Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation
Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Moore, S. Carbajal, L. Beltran, S. N. Perkins, S. Yakar, D. LeRoith, S. D. Hursting, and J. DiGiovanni
Reduced Susceptibility to Two-Stage Skin Carcinogenesis in Mice with Low Circulating Insulin-Like Growth Factor I Levels
Cancer Res., May 15, 2008; 68(10): 3680 - 3688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Huveneers, S. Arslan, B. van de Water, A. Sonnenberg, and E. H. J. Danen
Integrins Uncouple Src-induced Morphological and Oncogenic Transformation
J. Biol. Chem., May 9, 2008; 283(19): 13243 - 13251.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Lu, O. Rho, E. Wilker, L. Beltran, and J. DiGiovanni
Activation of Epidermal Akt by Diverse Mouse Skin Tumor Promoters
Mol. Cancer Res., December 1, 2007; 5(12): 1342 - 1352.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Honda, T. Sakaguchi, K. Sakai, C. Schmedt, A. Ramirez, J. L. Jorcano, A. Tarakhovsky, H. Kamisoyama, and T. Sakai
Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk
Carcinogenesis, October 1, 2007; 28(10): 2074 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Huveneers, I. van den Bout, P. Sonneveld, A. Sancho, A. Sonnenberg, and E. H.J. Danen
Integrin {alpha}v{beta}3 Controls Activity and Oncogenic Potential of Primed c-Src
Cancer Res., March 15, 2007; 67(6): 2693 - 2700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Lomada, B. Liu, L. Coghlan, Y. Hu, and E. R. Richie
Thymus Medulla Formation and Central Tolerance Are Restored in IKK{alpha}-/- Mice That Express an IKK{alpha} Transgene in Keratin 5+ Thymic Epithelial Cells
J. Immunol., January 15, 2007; 178(2): 829 - 837.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Ohkumo, Y. Kondo, M. Yokoi, T. Tsukamoto, A. Yamada, T. Sugimoto, R. Kanao, Y. Higashi, H. Kondoh, M. Tatematsu, et al.
UV-B Radiation Induces Epithelial Tumors in Mice Lacking DNA Polymerase {eta} and Mesenchymal Tumors in Mice Deficient for DNA Polymerase {iota}
Mol. Cell. Biol., October 15, 2006; 26(20): 7696 - 7706.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
I. Mikaelian, M. Hovick, K. A. Silva, L. M. Burzenski, L. D. Shultz, C. L. Ackert-Bicknell, G. A. Cox, and J. P. Sundberg
Expression of Terminal Differentiation Proteins Defines Stages of Mouse Mammary Gland Development
Vet. Pathol., January 1, 2006; 43(1): 36 - 49.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Karni, Y. Gus, Y. Dor, O. Meyuhas, and A. Levitzki
Active Src Elevates the Expression of {beta}-Catenin by Enhancement of Cap-Dependent Translation
Mol. Cell. Biol., June 15, 2005; 25(12): 5031 - 5039.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder
Src Family Kinase Inhibitors Block Amphiregulin-Mediated Autocrine ErbB Signaling in Normal Human Keratinocytes
Mol. Pharmacol., April 1, 2005; 67(4): 1145 - 1157.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li, C. Marshall, L. Mei, L. Dzubow, C. Schmults, M. Dans, and J. Seykora
Srcasm Modulates EGF and Src-kinase Signaling in Keratinocytes
J. Biol. Chem., February 18, 2005; 280(7): 6036 - 6046.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.